Opportunity Information: Apply for PAR 18 890

This funding opportunity (PAR-18-890) is a limited-competition NIH cooperative agreement announcement from the National Institute on Aging (NIA). It is aimed specifically at organizations that already hold active NIA-supported Cooperative Agreements (U01s) focused on the genetics of Alzheimer s disease and Alzheimer s disease related dementias (AD/ADRD). The mechanism is a cooperative agreement, meaning the NIH expects substantial programmatic involvement and coordination with awardees rather than a hands-off grant relationship. It is also labeled "Clinical Trial Not Allowed," signaling that the work proposed under this revision request is not intended to initiate or run clinical trials, but instead to expand or enhance research activities tied to genetics and sequencing.

The purpose of the announcement is to invite revision applications (often called administrative supplements or competitive revisions depending on the structure) to add work that supports the Alzheimer s Disease Sequencing Project (ADSP) Follow-Up Study. In practical terms, the FOA is focused on generating additional high-quality genetic data and associated analyses to strengthen ADSP follow-up efforts. The scope described is very specific to the sequencing and genetics pipeline: acquiring appropriate samples, conducting genome-wide association studies (GWAS), performing whole genome sequencing (WGS), and carrying out the downstream bioinformatics and data processing steps needed to make the resulting datasets usable for research. That includes quality control checks, variant calling, and data calling, all of which are core steps in turning raw sequencing reads into reliable lists of genetic variants and curated datasets that can be shared and analyzed across the research community.

Because this is a limited competition, it is not a general open call for any new applicant to start an ADSP sequencing project from scratch. Instead, it is designed for existing NIA-funded U01 teams already working in this space, allowing them to request revisions to their ongoing projects so they can contribute additional sequencing, genotyping, or analytic capacity aligned with the ADSP Follow-Up Study. The overall intent is to accelerate and broaden the generation of comparable, harmonized genetic data relevant to Alzheimer s disease and related dementias, which can improve statistical power for discovery, support replication of findings, and enable deeper analyses of risk variants and biological pathways.

Eligibility in the source information lists a wide range of domestic organization types that can generally apply to NIH opportunities, including state and local governments, public and private institutions of higher education, federally recognized tribal governments, tribal organizations, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, special district governments, and certain housing authorities. The description also explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISI), as well as faith-based or community-based organizations and eligible federal agencies. At the same time, the FOA draws a firm boundary around foreign involvement: non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed. In other words, the work and organizational participation must remain fully domestic under NIH rules for this program.

From an administrative standpoint, the opportunity falls under the NIH health research activity category, with CFDA number 93.866, and uses the cooperative agreement funding instrument. The opportunity was created on 2018-08-03, and the original closing date listed is 2021-09-07. The excerpted source data does not provide an award ceiling or expected number of awards, which typically means applicants would need to consult the full FOA or NIH documentation for budget limits, project period constraints, and any ADSP-specific expectations about sample numbers, sequencing depth, data submission timelines, or coordination requirements.

In summary, this FOA is a targeted request for competitive revision applications from currently funded NIA U01 cooperative agreement holders in AD/ADRD genetics, with the goal of generating additional sequencing and genetics datasets for the ADSP Follow-Up Study. It emphasizes end-to-end genomic data production and processing (from sample acquisition through QC and variant calling) and restricts participation to domestic organizations and domestic components only, while excluding clinical trial activities.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2018-08-03.
  • Applicants must submit their applications by 2021-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 890

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional)

Previous opportunity: U.S. Embassy Banjul Political Economic Section FY 2017 Fiscal

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 890

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 890) also looked into and applied for these:

Funding Opportunity
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection (U01 Clinical Trial Not Allowed) Apply for RFA NS 18 033

Funding Number: RFA NS 18 033
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 18 027

Funding Number: RFA RM 18 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed) Apply for RFA RM 18 026

Funding Number: RFA RM 18 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA NS 18 034

Funding Number: RFA NS 18 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 18 028

Funding Number: RFA RM 18 028
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37) Apply for RFA MD 18 007

Funding Number: RFA MD 18 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) Apply for PAR 18 894

Funding Number: PAR 18 894
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) Apply for PAR 18 895

Funding Number: PAR 18 895
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required) Apply for RFA AG 19 020

Funding Number: RFA AG 19 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for RFA MH 19 240

Funding Number: RFA MH 19 240
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 899

Funding Number: PAR 18 899
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 037

Funding Number: RFA RM 18 037
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 900

Funding Number: PAR 18 900
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed) Apply for RFA CA 19 004

Funding Number: RFA CA 19 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,999
Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 (Collab) Clinical Trial Not Allowed) Apply for PAR 18 905

Funding Number: PAR 18 905
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial Not Allowed) Apply for PAR 18 904

Funding Number: PAR 18 904
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed) Apply for RFA MD 18 011

Funding Number: RFA MD 18 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,300,000
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Apply for PA 18 906

Funding Number: PA 18 906
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 031

Funding Number: RFA RM 18 031
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 032

Funding Number: RFA RM 18 032
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 890", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: